77 related articles for article (PubMed ID: 6982001)
1. Sequential in vitro reactivity of lymphocytes from patients with cervical squamous malignancy in a cytotoxicity assay.
Dini MM; Faiferman I
Am J Obstet Gynecol; 1982 Oct; 144(3):341-5. PubMed ID: 6982001
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic blocking activity in invasive squamous cell carcinoma of the human uterine cervix.
Dini MM; Faiferman I
Cancer; 1980 Dec; 46(12):2573-6. PubMed ID: 7448696
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
[TBL] [Abstract][Full Text] [Related]
4. Divergence between the occurrence of antibody and cellular immune reactivity to cervical carcinoma cell lines in preinvasive and macroinvasive stages of cervical carcinoma.
van de Linde AW; Streefkerk M; Schuurman HJ; te Velde ER; Kater L
Br J Cancer; 1983 Jan; 47(1):147-53. PubMed ID: 6821628
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated cytotoxicity in preinvasive and invasive squamous cell carcinoma of the cervix.
Dini MM; Jafari K; Faiferman I
Obstet Gynecol; 1980 Jun; 55(6):728-31. PubMed ID: 7383460
[TBL] [Abstract][Full Text] [Related]
6. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up.
Garzetti GG; Ciavattini A; Muzzioli M; Goteri G; Mannello B; Romanini C; Fabris N
Gynecol Obstet Invest; 1995; 40(2):133-8. PubMed ID: 8575692
[TBL] [Abstract][Full Text] [Related]
8. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
Gosselin P; Cazin JL; Dehaut JP; Sulman C; Baranzelli MC; Demaille MC
Presse Med; 1987 Oct; 16(34):1677-9. PubMed ID: 2959941
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
Dini MM; Lenzi L; Faiferman I
Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated cytotoxicity against HeLa cells in patients with invasive or preinvasive cervical cancer.
Saksela E; Meyer B
J Natl Cancer Inst; 1973 Oct; 51(4):1095-102. PubMed ID: 4745849
[No Abstract] [Full Text] [Related]
12. Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
Chen SS; Koffler D; Cohen CJ
Am J Obstet Gynecol; 1975 Jan; 121(1):91-5. PubMed ID: 1115121
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological analysis of cervical basaloid squamous cell carcinoma].
Wang LQ; Wang Y; Jin W; Cao C; Ma YQ; Ding XH; Liu AJ
Zhonghua Fu Chan Ke Za Zhi; 2019 Jan; 54(1):7-12. PubMed ID: 30695899
[No Abstract] [Full Text] [Related]
15. Three-dimensional power Doppler ultrasound in cervical carcinoma: monitoring treatment response to radiotherapy.
Huang YF; Cheng YM; Wu YP; Chen HH; Hsu KF; Wu YH; Chou CY
Ultrasound Obstet Gynecol; 2013 Jul; 42(1):84-92. PubMed ID: 22744872
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
Fuith LC; Daxenbichler G
Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
[TBL] [Abstract][Full Text] [Related]
17. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].
Römisch M; Meier W; Kimmig R; Hepp H
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064
[TBL] [Abstract][Full Text] [Related]
18. Immunological aspects of gynecological malignancies.
DiSaia PJ
J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
[TBL] [Abstract][Full Text] [Related]
19. [Killing activity of cytotoxic T lymphocytes stimulated by dendritic cell vaccine loaded with autologous cervical cancer antigen].
Zhou CJ; Ma W; Zhou JD; Zhao YX; Xie HQ
Ai Zheng; 2006 Feb; 25(2):143-7. PubMed ID: 16480575
[TBL] [Abstract][Full Text] [Related]
20. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
Göcze P; Vahrson H
Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
